Liquidia Corp (LQDA)
12.70
-0.04
(-0.31%)
USD |
NASDAQ |
May 17, 16:00
12.70
0.00 (0.00%)
After-Hours: 20:00
Liquidia Total Assets (Quarterly): 197.12M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 197.12M |
December 31, 2023 | 118.33M |
September 30, 2023 | 111.64M |
June 30, 2023 | 121.60M |
March 31, 2023 | 128.92M |
December 31, 2022 | 129.20M |
September 30, 2022 | 132.57M |
June 30, 2022 | 139.08M |
March 31, 2022 | 93.52M |
December 31, 2021 | 93.73M |
September 30, 2021 | 100.30M |
June 30, 2021 | 104.38M |
March 31, 2021 | 88.45M |
Date | Value |
---|---|
December 31, 2020 | 99.53M |
September 30, 2020 | 91.11M |
June 30, 2020 | 35.43M |
March 31, 2020 | 52.78M |
December 31, 2019 | 68.84M |
September 30, 2019 | 52.24M |
June 30, 2019 | 64.71M |
March 31, 2019 | 73.72M |
December 31, 2018 | 49.42M |
September 30, 2018 | 57.23M |
June 30, 2018 | 20.78M |
March 31, 2018 | 29.23M |
December 31, 2017 | 14.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
35.43M
Minimum
Jun 2020
197.12M
Maximum
Mar 2024
101.17M
Average
99.92M
Median
Total Assets (Quarterly) Benchmarks
United Therapeutics Corp | 6.495B |
AIM ImmunoTech Inc | 19.38M |
Perspective Therapeutics Inc | 278.29M |
Protalix BioTherapeutics Inc | 89.82M |
Armata Pharmaceuticals Inc | 120.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 110.86M |
Shareholders Equity (Quarterly) | 86.26M |
Current Ratio | 7.660 |
Net Debt Paydown Yield | 0.35% |